May 22, 2023 / 06:00PM GMT
Operator
Good afternoon and welcome to the Akari Therapeutics KOL event. (Operator Instructions)
As a reminder, this call is being recorded and a replay will be made available on the Akari website following the conclusion of the event.
I'd now like to turn the call over to Rachelle Jacques, President and Chief Executive Officer of Akari Therapeutics. Please go ahead, Rachelle.
Rachelle Jacques - Akari Therapeutics, Plc - President & CEO
Thanks, Tara, and welcome, everybody. As Tara mentioned, I'm Rachelle Jacques, CEO of Akari Therapeutics and really pleased to have you all here today. Thank you for joining our key opinion leader event, and we're going to focus today on geographic atrophy and the potential of long-acting PASylated-nomacopan to address significant needs in the area. So today's webinar is going to be featuring Dr. Elias Reichel.
Of course, we are going to be making forward-looking statements so just take note there, please.
Let me now introduce Dr. Reichel who is going to give us a brief overview of geographic
Akari Therapeutics PLC To Host a Virtual Key Opinion Leader Event Transcript
May 22, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers